# Royal Russian Reishi (Ganoderma lucidum 'Royal Russian')

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/royal-russian-reishi
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Mushroom/Fungi
**Also Known As:** Ganoderma lucidum 'Royal Russian', Royal Russian Lingzhi, Royal Russian variety Reishi, Ganoderma lucidum cultivar Royal Russian, Royal Russian medicinal mushroom, Enhanced Reishi Royal Russian, Royal Russian Ganoderma

## Overview

Royal Russian Reishi (Ganoderma lucidum 'Royal Russian') is a cultivated variant of Ganoderma lucidum rich in triterpenoids (ganoderic acids) and beta-glucan polysaccharides that modulate [immune function](/ingredients/condition/immune-support) by activating NK cells and shifting CD4/CD8 T-cell ratios. Its primary mechanism involves beta-glucan binding to Dectin-1 and TLR-2 receptors on macrophages, triggering downstream [NF-κB](/ingredients/condition/inflammation) signaling to upregulate innate and adaptive immune responses.

## Health Benefits

• May improve quality of life in cancer patients when combined with conventional therapy (moderate evidence from meta-analysis of 5 RCTs)
• Potential immune enhancement through increased NK-cell activity and improved CD4/CD8 ratio (moderate evidence from cancer studies)
• Patient-reported improvements in fatigue, sleep, pain, and anxiety/depression in 48-64% of cancer patients (observational data from 1374 patients)
• Possible analgesic effects in rheumatoid arthritis patients (limited evidence from one RCT)
• No demonstrated benefits for [cardiovascular risk](/ingredients/condition/heart-health) factors or hyperglycemia (negative results from RCTs)

## Mechanism of Action

[Beta-glucan](/ingredients/condition/immune-support) polysaccharides in Royal Russian Reishi bind to pattern-recognition receptors Dectin-1 and TLR-2 on dendritic cells and macrophages, activating [NF-κB](/ingredients/condition/inflammation) and MAPK signaling cascades that upregulate IL-2, IL-6, TNF-alpha, and interferon-gamma production. Ganoderic acids (particularly ganoderic acid A, B, and C) inhibit 5-alpha reductase and HMG-CoA reductase, and exhibit cytotoxic activity against certain tumor cell lines via caspase-3-mediated apoptosis. These dual pathways collectively enhance NK-cell cytotoxicity and improve CD4+/CD8+ T-lymphocyte ratios, supporting both innate and adaptive immune surveillance.

## Clinical Summary

A meta-analysis of 5 randomized controlled trials examining Ganoderma lucidum adjunct therapy in cancer patients found statistically significant improvements in quality-of-life scores and immune markers, including increased NK-cell activity and improved CD4/CD8 ratios compared to conventional treatment alone. Sample sizes in constituent trials ranged from approximately 30 to 100 participants, predominantly examining colorectal, lung, and breast cancer populations over 12-week intervention periods. Patient-reported outcomes including fatigue, pain tolerance, and overall well-being showed moderate improvements, though evidence is constrained by heterogeneity in extract standardization and dosing protocols across studies. Evidence quality is rated moderate; large-scale, well-standardized RCTs specific to the 'Royal Russian' cultivar are absent, limiting cultivar-specific efficacy conclusions.

## Nutritional Profile

Ganoderma lucidum (Reishi) nutritional composition per 100g dried fruiting body (note: 'Royal Russian' is a cultivar designation with limited cultivar-specific data; values reflect species baseline with noted variations): Macronutrients — Protein: 7–18g (contains all essential amino acids; glutamic acid, aspartic acid, and lysine are dominant); Carbohydrates: 26–28g total, of which dietary fiber constitutes 59–78% of dry weight (predominantly insoluble [beta-glucan](/ingredients/condition/immune-support)s and chitin); Fat: 1.1–3.5g (including oleic acid, stearic acid, and palmitic acid as primary fatty acids); Moisture in dried form: ~12%. Key Bioactive Compounds — Beta-D-glucans (1,3 and 1,6 linkages): 10–50% of dry weight depending on extraction method and growing substrate; Triterpenoids (ganoderic acids A, B, C, D, G, H, and lucidenic acids): 1–3% of dry weight in fruiting body, up to 6% in spore powder; Polysaccharides (including GL-PS and GLPS fractions): 1.1–5.4g/100g; Adenosine: ~0.1–0.5mg/g dry weight (vasodilatory activity). Micronutrients — Potassium: 330–460mg/100g; Phosphorus: 220–320mg/100g; Magnesium: 19–28mg/100g; Calcium: 18–28mg/100g; Zinc: 1.8–4.2mg/100g; Iron: 3.5–5.6mg/100g; Selenium: 0.9–2.1mcg/g (substrate-dependent, notably higher in selenium-enriched cultivation). Vitamins — Ergosterol (provitamin D2 precursor): 0.3–0.8mg/g dry weight, converting to vitamin D2 upon UV exposure; B-vitamins present in modest amounts: Niacin (B3): 4.7–7.9mg/100g; Riboflavin (B2): 0.4–0.9mg/100g; Thiamine (B1): 0.2–0.5mg/100g. Bioavailability Notes — Beta-glucans and polysaccharides have low oral bioavailability in native form; hot-water extraction (decoction at 80–100°C for 60+ min) significantly improves polysaccharide solubility and absorption; triterpenoids require ethanol or dual extraction for adequate solubilization; chitin cell walls limit direct nutrient absorption from raw/unprocessed material; spore powder (cracked/broken spore) delivers 10–70x higher triterpenoid concentration versus fruiting body per gram; 'Royal Russian' cultivar designation suggests cold-climate adaptation which may increase triterpenoid density (cold-[stress response](/ingredients/condition/stress) documented in Ganoderma species) but cultivar-specific analytical data is not yet published in peer-reviewed literature.

## Dosage & Preparation

Clinically studied doses range from 4g daily of whole powder (used for 24 weeks in rheumatoid arthritis) to varied extract forms in cancer adjuvant therapy. Polysaccharide extracts have been studied but specific doses were not detailed in available abstracts. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Royal Russian Reishi is generally well tolerated at typical supplemental doses (1.5–9 g dried extract daily), with reported adverse effects including mild gastrointestinal upset, dry mouth, and dizziness in a minority of users during prolonged use exceeding 3–6 months. Clinically significant drug interactions include potentiation of anticoagulant and antiplatelet agents (warfarin, clopidogrel, aspirin) due to inhibition of platelet aggregation, warranting INR monitoring if co-administered. [Immunomodulatory](/ingredients/condition/immune-support) activity may interfere with immunosuppressant drugs such as cyclosporine or tacrolimus, and caution is advised in organ transplant recipients. Safety in pregnancy and lactation has not been established in controlled studies, and use is not recommended during these periods.

## Scientific Research

Clinical evidence comes from meta-analyses and RCTs primarily in cancer and rheumatoid arthritis populations, though no studies specifically examined the 'Royal Russian' cultivar. A meta-analysis (PMC6353236) of 5 RCTs with 373 cancer patients showed improved quality of life scores and immune parameters, while an RCT in 65 RA patients (PMID: 17907228) found only analgesic effects without [anti-inflammatory](/ingredients/condition/inflammation) benefits.

## Historical & Cultural Context

Ganoderma lucidum (Lingzhi in China, Reishi in Japan) has been used for over 2000 years in Traditional Chinese Medicine as a vitality-enhancing tonic for [longevity](/ingredients/condition/longevity), [immune support](/ingredients/condition/immune-support), and general health. Historically prized as a medicinal mushroom for cancer-like symptoms, fatigue, and [inflammation](/ingredients/condition/inflammation) in Asian traditional medicine systems.

## Synergistic Combinations

Turkey Tail, Cordyceps, Astragalus, Green Tea Extract, Vitamin D3

## Frequently Asked Questions

### What is the recommended dosage of Royal Russian Reishi supplement?

Typical dosages studied in clinical trials for Ganoderma lucidum range from 1.5 g to 9 g of dried mushroom extract per day, often divided into two or three doses. Standardized extracts concentrated to a specific percentage of polysaccharides (commonly 10–30%) or triterpenoids are preferred because raw mushroom powder requires substantially higher quantities to deliver equivalent active compound levels. No cultivar-specific dosing guidelines exist for the 'Royal Russian' variant, so following the manufacturer's standardization label is currently the most practical guidance.

### Can Royal Russian Reishi be taken with blood thinners like warfarin?

Royal Russian Reishi should be used with caution alongside anticoagulants such as warfarin or antiplatelet drugs like clopidogrel, because ganoderic acid compounds inhibit platelet aggregation and may amplify bleeding risk. Clinical case reports and in vitro studies have documented additive effects on coagulation parameters, including prolonged prothrombin time. Patients on anticoagulant therapy should consult a healthcare provider before use, and INR monitoring is advisable if concurrent supplementation is pursued.

### How does Royal Russian Reishi support the immune system?

Royal Russian Reishi's beta-1,3/1,6-glucan polysaccharides bind to Dectin-1 and TLR-2 receptors on macrophages and dendritic cells, activating NF-κB signaling and increasing production of cytokines including IL-2, IL-6, and interferon-gamma. This cascade enhances NK-cell cytotoxicity and improves the CD4+/CD8+ T-lymphocyte ratio, both markers of a more robust adaptive immune response. Cancer-adjunct studies have quantified NK-cell activity increases of roughly 15–25% over control groups, though results vary considerably by extract type and patient population.

### Is Royal Russian Reishi the same as regular Reishi mushroom?

Royal Russian Reishi is a specific cultivar of Ganoderma lucidum developed through selective cultivation practices, and while it shares the same species designation and core bioactives (beta-glucans, ganoderic acids), its exact polysaccharide and triterpenoid profile may differ quantitatively from wild-harvested or other commercially cultivated strains. No published head-to-head comparative trials between the 'Royal Russian' cultivar and standard Ganoderma lucidum extracts exist, so efficacy equivalence cannot be confirmed. Consumers should check standardization certificates to compare active compound concentrations rather than relying on cultivar naming alone.

### How long does it take for Royal Russian Reishi to work?

Clinical trials using Ganoderma lucidum in cancer-adjunct settings typically report measurable changes in immune markers such as NK-cell activity and CD4/CD8 ratios within 4 to 12 weeks of consistent daily supplementation. Patient-reported quality-of-life improvements, including reduced fatigue and improved pain tolerance, generally emerged between weeks 8 and 12 in the reviewed RCTs. Individual response times vary depending on baseline immune status, extract potency, dosage, and the specific health outcome being targeted.

### What does clinical research show about Royal Russian Reishi for cancer patients?

A meta-analysis of 5 randomized controlled trials found moderate evidence that Royal Russian Reishi may improve quality of life when combined with conventional cancer therapy. Studies also demonstrate potential immune enhancement through increased NK-cell activity and improved CD4/CD8 ratios in cancer populations. However, Royal Russian Reishi should always be used as a complementary treatment alongside conventional medical care, not as a replacement.

### Who benefits most from Royal Russian Reishi supplementation?

Royal Russian Reishi may be most beneficial for individuals undergoing cancer treatment or those with chronic stress-related conditions, as observational data shows 48-64% of cancer patients reported improvements in fatigue, sleep, pain, and anxiety/depression symptoms. It may also benefit those seeking immune support or natural stress management, though results vary individually. People with compromised immune systems or those on immunosuppressive medications should consult a healthcare provider before use.

### Is Royal Russian Reishi safe for people taking cancer medications or chemotherapy?

Royal Russian Reishi has been studied alongside conventional cancer therapies in clinical trials with moderate safety evidence, but it may interact with certain chemotherapy drugs or immunosuppressants through its immune-modulating effects. Anyone undergoing cancer treatment must consult their oncologist before adding Royal Russian Reishi, as timing and drug-supplement interactions require professional oversight. Individual health status and medication regimen should guide safety decisions in this population.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*